The approval follows the positive recommendation from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) in October 2022
The proceeds of the issue has been/will be reinvested in the company and to meet its own business requirements.
These satellite institutes will further strengthen the research, international collaborations and facilitate affordable Ayush services for the larger community.
More women centric initiatives being the need of the hour for holistic development
The funds raised through the issue will be utilised to meet the working capital requirements to fund the company's expansion plans, entering new geographies and for general corporate purposes
GMP-compliant documentation of all manufacturing steps for cell and gene therapies
Shandong Meditech Medical Technology is a manufacturer of onsite oxygen solutions for the healthcare market.
The use of procalcitonin testing for sepsis management is highest in the US
The IPO is a complete OFS by existing shareholder Helix Investment Holdings
Subscribe To Our Newsletter & Stay Updated
